Effects of Genetic Variants Previously Associated with Fasting Glucose and Insulin in the Diabetes Prevention Program

• Jose C. Florez ,

  * E-mail: dppmail@biostat.bsc.gwu.edu (DPPRG); jcflorez@partners.org (JCF)

  Affiliations Center for Human Genetic Research and Diabetes Research Center (Diabetes Unit), Massachusetts General Hospital, Boston, Massachusetts, United States of America, Program in Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts, United States of America, Department of Medicine, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Kathleen A. Jablonski,

  Affiliation The Biostatistics Center, George Washington University, Rockville, Maryland, United States of America

  ⨯
• Jarred B. McAteer,

  Affiliations Center for Human Genetic Research and Diabetes Research Center (Diabetes Unit), Massachusetts General Hospital, Boston, Massachusetts, United States of America, Program in Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts, United States of America

  ⨯
• Paul W. Franks,

  Affiliations Lund University Diabetes Center, Department of Clinical Sciences, Lund University, Malmö, Sweden, Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts, United States of America

  ⨯
• Clinton C. Mason,

  Affiliation Diabetes Epidemiology and Clinical Research Section, National Institute of Diabetes and Digestive and Kidney Diseases, Phoenix, Arizona, United States of America

  ⨯
• Kieren Mather,

  Affiliation Division of Endocrinology, Indiana University School of Medicine, Indianapolis, Indiana, United States of America

  ⨯
• Edward Horton,

  Affiliations Department of Medicine, Harvard Medical School, Boston, Massachusetts, United States of America, Joslin Diabetes Center, Boston, Massachusetts, United States of America

  ⨯
• Ronald Goldberg,

  Affiliation Lipid Disorders Clinic, Division of Endocrinology, Diabetes, and Metabolism, and the Diabetes Research Institute, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida, United States of America

  ⨯
• Dana Dabelea,

  Affiliation Department of Preventive Medicine and Biometrics, University of Colorado at Denver and Health Sciences Center, Denver, Colorado, United States of America

  ⨯
• Steven E. Kahn,

  Affiliation Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, VA Puget Sound Health Care System and University of Washington, Seattle, Washington, United States of America

  ⨯
• Richard F. Arakaki,

  Affiliation Department of Medicine Clinical Research, University of Hawaii, Honolulu, Hawaii, United States of America

  ⨯
• Alan R. Shuldiner,

  Affiliation Division of Endocrinology, Diabetes and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, United States of America

  ⨯
• William C. Knowler, for the Diabetes Prevention Program Research Group

  A list of Diabetes Prevention Program Research Group investigators is provided in the Appendix S1.

  Affiliation Diabetes Epidemiology and Clinical Research Section, National Institute of Diabetes and Digestive and Kidney Diseases, Phoenix, Arizona, United States of America

  ⨯